Skip to main content

Advertisement

Log in

Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Brunning RD, Matutes E, Flandrin G, Vardiman J, Bennet J, Head D et al. Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC press: Lyon, 2001, pp 89–91.

    Google Scholar 

  2. Vicari AM, Ciceri F, Folli F, Lanzi R, Colombo B, Comi G et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia 1998; 12: 441–442.

    Article  CAS  PubMed  Google Scholar 

  3. Cattaneo C, Almici C, Borlenghi E, Motta M, Rossi G . A case of acute promyelocytic leukemia following mitoxantrone treatment of multiple sclerosis. Leukemia 2003; 17: 986–987.

    Article  Google Scholar 

  4. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003; 11: 2123–2137.

    Article  Google Scholar 

  5. Novoselac AV, Reddy S, Sanmugarajah J . Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia 2004; 18: 1561–1562.

    Article  CAS  PubMed  Google Scholar 

  6. Arruda OW, Montú MB, de Oliveira Mde S, Ramina R . Acute myeloid leukaemia induced by mitoxantrone. Arq Neuropsiquiatr 2005; 63: 327–329.

    Article  PubMed  Google Scholar 

  7. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. GIMEMA and AIEOP Cooperative Groups. Blood 1997; 90: 1014–1021.

    CAS  PubMed  Google Scholar 

  8. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, Cassinat B et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N Engl J Med 2005; 352: 1529–1538.

    Article  CAS  PubMed  Google Scholar 

  9. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601–2607.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ledda, A., Caocci, G., Spinicci, G. et al. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis. Leukemia 20, 2217–2218 (2006). https://doi.org/10.1038/sj.leu.2404443

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404443

  • Springer Nature Limited

This article is cited by

Navigation